Efficient Delivery of p53 and Cytochrome C by Supramolecular Assembly of a Dendritic Multi‐Domain Delivery System
- 8 May 2013
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 2 (12) , 1620-1629
Abstract
Versatile nanocarrier systems facilitating uptake of exogenous proteins are highly alluring in evaluating these proteins for therapeutic applications. The self‐assembly of an efficient nano‐sized protein transporter consisting of three different entities is presented: A streptavidin protein core functioning as an adapter, second generation polyamidoamine dendrons for facilitating cell uptake as well as two different therapeutic proteins (tumor suppressor p53 or pro‐apoptotic cytochrome c as cargo). Well‐defined dendrons containing a biotin core are prepared and display no cytotoxic behavior upon conjugation to streptavidin. The integration of biotinylated human recombinant p53 (B‐p53) into the three component system allows excellent internalization into HeLa, A549 and SaOS osteosarcoma cells monitored via confocal microscopy, immunoblot analysis and co‐localization studies. In addition, the conjugation of B‐p53 to dendronized streptavidin preserves its specific DNA‐binding in vitro, and its delivery into SaOS cells impairs cell viability with concomitant activation of caspases 3 and 7. The versatility of this system is further exhibited by the significant enhancement of the pro‐apoptotic effects of internalized cytochrome c which is analyzed by flow cytometry and cell viability assays. These results demonstrate that the “bio‐click” self‐assembly of biotinylated dendrons and proteins on a streptavidin adapter yields a stable supramolecular complex. This efficient bionanotransporter provides an attractive platform for mediating the delivery of functional proteins of interest into living mammalian cells in a facile and rapid way.Keywords
This publication has 44 references indexed in Scilit:
- Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applicationsDrug Discovery Today, 2010
- Intracellular Delivery of a Membrane-Impermeable Enzyme in Active Form Using Functionalized Gold NanoparticlesJournal of the American Chemical Society, 2010
- Genetically Engineered Clostridial C2 Toxin as a Novel Delivery System for Living Mammalian CellsBioconjugate Chemistry, 2009
- A novel intracellular protein delivery platform based on single-protein nanocapsulesNature Nanotechnology, 2009
- Clinical toxicities of nanocarrier systemsAdvanced Drug Delivery Reviews, 2008
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Live‐cell analysis of cell penetration ability and toxicity of oligo‐argininesJournal of Peptide Science, 2007
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic ProteinsClinical Pharmacokinetics, 2005
- Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain terminiProceedings of the National Academy of Sciences, 2001